SCHEMBL16670728

SCHEMBL16670728

Cc1cc(C(=O)/C=C/c2c(Cl)ccc(CNC(=O)C(C)(C)C)c2F)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.39
▸ LMNA P02545 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MDM4 O15151 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ EPHX2 P34913 8/20 0.35
▸ NR1H4 Q96RI1 6/20 0.35
▸ PTGES O14684 5/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PPARD Q03181 1/20 0.34
▸ PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16670731 1.00 DPP4 (0.39) DPP4LMNAHPGDALOX12ATM
SCHEMBL16671832 0.95 DPP4 (0.38) DPP4LMNAHPGDALOX12ATM
SCHEMBL16671833 0.95 DPP4 (0.38) DPP4LMNAHPGDALOX12ATM
SCHEMBL16671628 0.92 ALOX5 (0.40) LMNAHPGDALOX12ATMSMN1; SMN2
SCHEMBL16682194 0.92 ALOX5 (0.40) LMNAHPGDALOX12ATMSMN1; SMN2
SCHEMBL16671060 0.88 DDR1 (0.38) DPP4LMNAHPGDALOX12ATM
SCHEMBL16671059 0.88 DDR1 (0.38) DPP4LMNAHPGDALOX12ATM
SCHEMBL16682136 0.86 CYP1A1 (0.46) DPP4LMNAHPGDALOX12ATM
SCHEMBL16670998 0.78 CA1 (0.39) EPHX2NR1H4PTGESHDAC6
SCHEMBL16682176 0.76 DDR1 (0.35) EPHX2NR1H4PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015059618-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-30 — — WO disclosed
WO-2015059618-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-30 — — WO disclosed
Send feedback